Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05633017 · ClinicalTrials.gov registry record
Breathing With a Facemask Exercise Performance
A clinical trial, sponsored by CereVu Medical.
- Completed
- Registry status
- 52
- Enrollment target
NCT05633017 is a clinical trial that has completed, run by CereVu Medical. The registered enrollment target is 52 participants.
The verdict
NCT05633017 has completed, sponsored by CereVu Medical.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
This study will determine the dyspnea response in chronic lung disease volunteers during treadmill walking with and without added inspiratory resistance. This study will also determine the level of dyspnea and exercise sense of effort in individuals walking on a treadmill when elevations occur. Comparisons will be made of a participant's exercise response with and without increased inspiratory resistance. In this study, exercise performance will be analyzed based on physiological and perceptual measures. The participant will undergo two sessions: one session will be a standard exercise walking test without an inspiratory resistance; the other session will be the same standard exercise walking test while breathing with an inspiratory resistance equal to a N95 facemask (R=10-15 cmH2O/L/sec). Performance will be determined by physiological measures. Perception will be determined by scores based on numerical scales and automatically with the forehead Vitality remote monitoring sensor.
Interventions
- COMBINATION_PRODUCT CereVu Objective Dyspnea Score
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2022-11-29 |
| Est. Completion | 2024-09-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05633017
The ClinicalTrials.gov registry entry for NCT05633017 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CereVu Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CereVu Objective Dyspnea Score is the first listed.
NCT05633017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05633017 about?
NCT05633017 is a clinical study titled "Breathing With a Facemask Exercise Performance". This study will determine the dyspnea response in chronic lung disease volunteers during treadmill walking with and without added inspiratory resistance. This study will also determine the level of dyspnea and exercise sense of effort in individuals walking on a treadmill when elevations occur. Comp...
What is the current status of trial NCT05633017?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2022-11-29. Estimated completion is 2024-09-17.
What interventions are being tested in trial NCT05633017?
The interventions under investigation include: CereVu Objective Dyspnea Score (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05633017?
This trial is sponsored by CereVu Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.